🔎 Trials Near Me

Hem › Akut myeloid leukemi › Missouri › Kansas City

Kliniska studier för Akut myeloid leukemi i Kansas City, MO

15 studier för Akut myeloid leukemi söker deltagare vid platser i och runt Kansas City (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

RekryterarFas 2
  • University Health Truman Medical Center, Kansas City
  • University of Kansas Cancer Center - Briarcliff, Kansas City
  • University of Kansas Cancer Center - North, Kansas City
  • och 1 fler
Ålder 18 och äldre · Alla kön · Uppdaterad 5 okt. 2026 · NCT05564390

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RekryterarObservationsstudieFriska volontärer välkomna
  • Kansas City Veterans Affairs Medical Center, Kansas City
Ålder 40 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT05334069

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

RekryterarFas 2
  • University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi bort
Ålder 18 till 59 · Alla kön · Uppdaterad 28 sep. 2026 · NCT05554393

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

RekryterarFas 2
  • University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

RekryterarFas 2
  • University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi bort
Ålder 18 till 59 · Alla kön · Uppdaterad 22 sep. 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

RekryterarFas 2
  • University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

RekryterarFas 3
  • Children's Mercy Hospitals and Clinics, Kansas City
6 Months – 21 Years · Alla kön · Uppdaterad 17 sep. 2026 · NCT04293562

A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease

RekryterarFas 1
  • University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi bort
Ålder 18 till 75 · Alla kön · Uppdaterad 25 aug. 2026 · NCT05886049

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

RekryterarFas 3
  • The Children's Mercy Hospital - Adele Hall Campus, Kansas City
29 Days – 21 Years · Alla kön · Uppdaterad 24 aug. 2026 · NCT05183035

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

RekryterarFas 1
  • Children's Mercy Hospital of Kansas City, Kansas City
Ålder 1 till 30 · Alla kön · Uppdaterad 3 aug. 2026 · NCT06177067

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

RekryterarFas 3
  • University of Kansas Cancer Center, Westwood · 5 mi bort
Ålder 18 till 75 · Alla kön · Uppdaterad 17 juli 2026 · NCT05429632

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RekryterarObservationsstudie
  • Children's Mercy Hospital and Clinics, Kansas City
  • University of Kansas, Westwood · 5 mi bort
Alla åldrar · Alla kön · Uppdaterad 6 juli 2026 · NCT01351545

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

RekryterarFas 1
  • University of Kansas Cancer Center, Westwood · 5 mi bort
Ålder 18 till 65 · Alla kön · Uppdaterad 25 mars 2026 · NCT03533816

Akut myeloid leukemi-studier i andra städer

Andra studier i Kansas City

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.